Episode notes
This week, we have three interviews to mark Stand Up To Cancer Day. We have conversations with Simon Kerry, co-founder and CEO of Curve Therapeutics; Poolbeg Pharma CEO Jeremy Skillington; and Stefano Gulla, CSO of Kling Biotherapeutics.
Interview times:
03:12 Curve Therapeutics
21:32 Kling Bio
37:10 Poolbeg Pharma
Microcycles to address cancer
Curve Therapeutics, a private biotechnology company using its gene-encoded Microcycle discovery platform to build a pipeline of innovative cyclic peptide and small molecule drugs to address high priority intracellular disease targets, with an initial focus on cancer, immunology, and inflammation.
Keywords
biotechbiotechnologycancercytokine release syndromeSU2CPoolbeg PharmaKling BioCurve TherapeuticsB-cellsMicrocycles